LONDON Microchip-scale Sensium technology, being commercialized by Imperial College spin-out company Toumaz Technology was included in research in wireless body sensors and personalized healthcare demonstrated to Her Majesty the Queen when she opened the Institute of Biomedical Engineering (IBE) at Imperial College.
The royal party was hosted at the IBE by Professor Chris Toumazou, founding director and chief scientist of the institute, and whose ECG heart rate was monitored wirelessly via a 'Sensium-enabled' digital plaster – the size and dimensions of a nicotine patch – and displayed to guests on a plasma screen.
The Sensium technology will allow healthcare providers to remotely and continuously monitor multiple vital signs and other bio-markers from mobile individuals in real-time, via standard handheld devices such as mobile phones. This technology enables chronic disease patients to be wirelessly and non-intrusively monitored with minimal impact on their lifestyle, eliminating the need to spend lengthy and regular periods in hospital.
During the demonstration, Professor Toumazou's heart rate reading was transmitted to a personal digital assistant (PDA) held by leading heart surgeon Sir Magdi Yacoub. The Institute of biomedical Engineering at Imperial College London draws together engineers and medical researchers and clinicians from across Imperial to transform methods of medical diagnosis and treatment. Current research includes retinal implants that will restore sight by stimulating the cells in the eye that receive visual information, and the development of tiny implantable wireless blood pressure monitors, aimed at giving patients greater freedom of movement.